Global Gastrointestinal Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Drug Class;
Acid Neutralizers - Antacids, H2 Antagonists and Proton Pump Inhibitors, Anti-inflammatory Drugs, Antidiarrheal and Laxatives, Antiemetic and Antinauseants, Biologics and Others.Segmented by Administration;
Oral, Parenteral and Rectal.Segmented by Application;
Inflammatory Ulcerative Colitis, Irritable Bowel Syndrome, Crohn's Disease, Celiac Disease, Gastroenteritis and Others.Segmented by Distribution Channel;
Retail Pharmacies, Online Pharmacies and Hospital Pharmacies.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Gastrointestinal Drugs Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 78.5 |
2021 | 82.9 |
2022 | 84.1 |
2023 | 95.7 |
2024 | 105.7 |
2025 | 125.0 |
2026 | 129.9 |
2027 | 137.4 |
2028 | 153.3 |
2029 | 171.2 |
2030 | 196.8 |
In the year 2023, the Global Gastrointestinal Drugs Market was valued at USD 52,323.00 million. The size of this market is expected to increase to USD 73,623.71 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.
Global Gastrointestinal Drugs Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Gastrointestinal Drugs Market |
Study Period | 2020 - 2030 |
Base Year (for Gastrointestinal Drugs Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Gastrointestinal Drugs Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Gastrointestinal Drugs Market Analysis
In this report, the Global Gastrointestinal Drugs Market has been segmented by Drug Class, Administration, Application, Distribution Channel and Geography.
Global Gastrointestinal Drugs Market, Segmentation by Drug Class
The Global Gastrointestinal Drugs Market has been segmented by Drug Class into Acid Neutralizers, Anti-inflammatory Drugs, Antidiarrheal and Laxatives, Antiemetic and Antinauseants, Biologics and Others. The complete Global Gastrointestinal Drugs Market segmentation by Drug Class can be seen below:
- Global Gastrointestinal Drugs Market, By Drug Class
- Acid Neutralizers
- Antacids
- H2 Antagonists
- Proton Pump Inhibitors
- Anti-inflammatory Drugs
- Antidiarrheal and Laxatives
- Antiemetic and Antinauseants
- Biologics
- Others
- Acid Neutralizers
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Drug Classs mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Drug Class is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. The gastrointestinal drugs list or the gastrointestinal drug's classification according to the drug type are gastrointestinal drug antiacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, other drug types, and the study of the properties of these drugs is known as pharmacology gastrointestinal drugs. The industrial films market by type are ldpe, lldpe, pet, hdpe, pvc, pp, polyamide. Digestible sensors market by product type are strip, ingestible, invasive, wearable, implantable. The mobile gambling market by product type is segmented into poker, betting, lottery, casino, and others. The manuka honey market by type are distribution channelified intoumf 5+, umf 10+, umf 15+, umf 20+, others. By type, the 360 degree camera market is segmented into high-definition (hd) and ultra-high-definition (uhd). The cnc router market is segmented on the basis of type as stationary gantry type, movable gantry type, cross feed unit type. Oil well cement market by type is segmented into grade 0, high sulfate resistant, and moderate sulfate resistant.
Global Gastrointestinal Drugs Market, by Drug Class (USD Million), 2020 - 2030
# | Acid Neutralizers | Anti-inflammatory Drugs | Antidiarrheal and Laxatives | Antiemetic and Antinauseants | Biologics | Others |
---|---|---|---|---|---|---|
2020 | 77.2 | 105.0 | 96.3 | 100.4 | 86.0 | 65.4 |
2021 | 87.4 | 117.8 | 105.8 | 103.6 | 98.7 | 72.1 |
2022 | 100.6 | 137.9 | 118.9 | 112.4 | 116.0 | 76.8 |
2023 | 113.7 | 164.2 | 131.3 | 123.5 | 127.0 | 77.7 |
2024 | 126.5 | 180.8 | 152.6 | 127.0 | 136.9 | 87.6 |
2025 | 141.4 | 201.8 | 157.5 | 151.5 | 142.0 | 94.5 |
2026 | 168.0 | 202.8 | 187.3 | 165.1 | 154.7 | 95.7 |
2027 | 184.7 | 212.6 | 200.3 | 183.2 | 167.0 | 112.4 |
2028 | 192.7 | 234.7 | 227.2 | 203.6 | 198.7 | 116.0 |
2029 | 202.1 | 265.9 | 267.4 | 211.6 | 225.0 | 124.0 |
2030 | 235.2 | 289.0 | 317.4 | 241.1 | 227.3 | 139.2 |
Global Gastrointestinal Drugs Market, Segmentation by Administration
The Global Gastrointestinal Drugs Market has been segmented by Administration into Oral, Parenteral and Rectal. The complete Global Gastrointestinal Drugs Market segmentation by Administration can be seen below:
- Global Gastrointestinal Drugs Market, By Administration
- Oral
- Parenteral
- Rectal
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Administrations mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Administration is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Gastrointestinal Drugs Market, by Administration (USD Million), 2020 - 2030
# | Oral | Parenteral | Rectal |
---|---|---|---|
2020 | 62.7 | 109.0 | 92.4 |
2021 | 62.7 | 127.7 | 103.2 |
2022 | 70.5 | 152.7 | 105.6 |
2023 | 82.5 | 152.9 | 112.9 |
2024 | 91.0 | 160.6 | 124.5 |
2025 | 93.7 | 167.0 | 132.7 |
2026 | 100.6 | 198.2 | 134.9 |
2027 | 104.7 | 205.0 | 155.5 |
2028 | 118.2 | 227.9 | 162.9 |
2029 | 139.6 | 248.0 | 171.9 |
2030 | 142.1 | 285.3 | 194.2 |
Global Gastrointestinal Drugs Market, Segmentation by Application
The Global Gastrointestinal Drugs Market has been segmented by Application into Inflammatory Ulcerative Colitis, Irritable Bowel Syndrome, Crohn's Disease, Celiac Disease, Gastroenteritis and Others. The complete Global Gastrointestinal Drugs Market segmentation by Application can be seen below:
- Global Gastrointestinal Drugs Market, By Application
- Inflammatory Ulcerative Colitis
- Irritable Bowel Syndrome
- Crohn's Disease
- Celiac Disease
- Gastroenteritis
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Applications mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Application is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. The gastrointestinal medications or the gastrointestinal drug treatment can be given on the basis of application such as ulcerative colitis, irritable bowel syndrome, crohn's disease, celiac disease, gastroenteritis, other applications.
Global Gastrointestinal Drugs Market, by Application (USD Million), 2020 - 2030
# | Inflammatory Ulcerative Colitis | Irritable Bowel Syndrome | Crohn's Disease | Celiac Disease | Gastroenteritis | Others |
---|---|---|---|---|---|---|
2020 | 81.3 | 100.7 | 93.5 | 65.8 | 62.0 | 92.9 |
2021 | 85.5 | 108.5 | 108.1 | 71.2 | 74.3 | 101.3 |
2022 | 89.6 | 126.4 | 126.1 | 82.6 | 81.6 | 118.6 |
2023 | 104.3 | 129.6 | 135.3 | 96.6 | 90.9 | 132.6 |
2024 | 118.1 | 132.7 | 140.6 | 110.0 | 108.8 | 137.1 |
2025 | 122.4 | 141.6 | 149.8 | 122.6 | 117.7 | 141.3 |
2026 | 146.9 | 159.2 | 170.5 | 124.0 | 118.2 | 162.2 |
2027 | 149.9 | 164.0 | 189.0 | 143.3 | 120.0 | 181.4 |
2028 | 160.1 | 179.4 | 211.7 | 148.9 | 129.5 | 188.6 |
2029 | 174.2 | 185.3 | 239.7 | 170.4 | 135.5 | 194.2 |
2030 | 180.1 | 211.1 | 252.8 | 175.9 | 156.9 | 225.1 |
Global Gastrointestinal Drugs Market, Segmentation by Distribution Channel
The Global Gastrointestinal Drugs Market has been segmented by Distribution Channel into Retail Pharmacies, Online Pharmacies and Hospital Pharmacies. The complete Global Gastrointestinal Drugs Market segmentation by Distribution Channel can be seen below:
- Global Gastrointestinal Drugs Market, By Distribution Channel
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Distribution Channels mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Distribution Channel is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. The fpga market is segmented by distribution channel industry such as telecommunication, consumer electronics, automotive, industrial, military and aerospace, and other distribution channelr industries. On the basis of distribution channel, the identity and access management market is segmented into bfsi, telecom and it, energy, oil and gas, education, public sector and utilities, healthcare, and manufacturing. On the basis of distribution channel, the zinc sulphate market is segmented into healthcare, agriculture, chemical, textile. Counter-uas market on the basis of distribution channel is segmented into military & defense, commercial and homeland security. Hemodynamic monitoring systems market by distribution channel are distribution channelified into hospitals, clinics & ambulatory care center, and home care setting. Ethane market by distribution channel is segmented into packaging, automotive & transportation, construction, electricals & electronics, healthcare, power. Liquid polybutadiene [lpbd] market on the basis end use is segmented into automotive, chemical, industrial, housing & construction, electronics, and others.
Global Gastrointestinal Drugs Market, by Distribution Channel (USD Million), 2020 - 2030
# | Retail Pharmacies | Online Pharmacies | Hospital Pharmacies |
---|---|---|---|
2020 | 73.2 | 96.1 | 76.8 |
2021 | 75.0 | 108.5 | 79.5 |
2022 | 77.8 | 112.7 | 89.2 |
2023 | 78.2 | 122.0 | 91.2 |
2024 | 78.6 | 127.7 | 96.6 |
2025 | 80.8 | 150.1 | 114.3 |
2026 | 91.1 | 165.4 | 123.2 |
2027 | 104.5 | 182.7 | 140.2 |
2028 | 106.9 | 213.4 | 162.7 |
2029 | 112.6 | 223.8 | 191.1 |
2030 | 120.9 | 253.8 | 224.8 |
Global Gastrointestinal Drugs Market, Segmentation by Geography
In this report, the Global Gastrointestinal Drugs Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Gastrointestinal Drugs Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Gastrointestinal Drugs Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Gastrointestinal Drugs in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Gastrointestinal Drugs Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Gastrointestinal Drugs Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Gastrointestinal Drugs Market will be discussed in detail in the full report.
- The new opportunities in Global Gastrointestinal Drugs Market will be discussed in detail in the full report.
- Global Gastrointestinal Drugs Market Drivers will be discussed in detail in the full report.
- Global Gastrointestinal Drugs Market Restraints will be discussed in detail in the full report.
- Global Gastrointestinal Drugs Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Gastrointestinal Drugs Market. The opportunity map (by market segments; Drug Class, Administration, Application and Distribution Channel) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Gastrointestinal Drugs Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Gastrointestinal Drugs Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Gastrointestinal Drugs Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Gastrointestinal Drugs Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. Key market players in the outdoor performance apparel are columbia sportswear company, cotswold outdoor ltd, jacobs & turner ltd (nevisport ltd), kathmandu limited, mountain warehouse limited, patagonia, snowgum australia pty limited (snowgum). Columbia sportswear company, cotswold outdoor ltd, jacobs & turner ltd (nevisport ltd), kathmandu limited, mountain warehouse limited, patagonia, and snowgum australia pty limited are key market players in outdoor performance apparel (snowgum). Adobe systems incorporated, amobee inc., clarivoy, dc analytics, edgeware ab, google llc, and others are key market players in the tv analytics market. Magnet wire market players include ls cable & system ltd., rea, irce spa, elektrisola, tongling jingxun special enamelled wire co ltd., and others.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Gastrointestinal Drugs Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Gastrointestinal Drugs Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Gastrointestinal Drugs Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Gastrointestinal Drugs Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Gastrointestinal Drugs Market include, Takeda Pharmaceticals, Allergan Plc, Novo Nordisk A/S, AstraZeneca Plc, AbbVie Inc., Valeant Pharmaceuticals Inc, Johnson & Johnson, Bayer AG and Boehringer Ingelheim GmbH.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Opportunity Map
- Global Gastrointestinal Drugs Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Gastrointestinal Drugs Market, By Drug Class, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Acid Neutralizers
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Antacids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- H2 Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Proton Pump Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Antacids
- Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Antidiarrheal and Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Antiemetic and Antinauseants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Acid Neutralizers
- Global Gastrointestinal Drugs Market, By Administration, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Rectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Oral
- Global Gastrointestinal Drugs Market, By Application, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Inflammatory Ulcerative Colitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Irritable Bowel Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Crohn's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Celiac Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Gastroenteritis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Inflammatory Ulcerative Colitis
- Global Gastrointestinal Drugs Market, By Distribution Channel, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Retail Pharmacies
- Global Gastrointestinal Drugs Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Administration, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Gastrointestinal Drugs Market, By Drug Class, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Takeda Pharmaceticals
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Allergan Plc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Novo Nordisk A/S
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- AstraZeneca Plc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- AbbVie Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Valeant Pharmaceuticals Inc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Johnson & Johnson
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Bayer AG
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Boehringer Ingelheim GmbH
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Takeda Pharmaceticals
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Gastrointestinal Stromal Tumors Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Gastroparesis Treatment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Gastroscopes Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Gel Documentation Systems Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%